Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo

Mucosal Immunology

Volumn 3, Issue 1, 2010, Pages 29-39

  Nhu, Q M ^a   Shirey, K ^a   Teijaro, J R ^a   Farber, D L ^a   Netzel Arnett, S ^a   Antalis, T M ^a   Fasano, A ^a   Vogel, S N ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CXCL2 CHEMOKINE; CYCLOOXYGENASE 2; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEINASE ACTIVATED RECEPTOR 2; RANTES; STAT1 PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOSENSOR; CELL LINE; CONTROLLED STUDY; CYTOKINE RELEASE; EPITHELIUM CELL; FOOT EDEMA; FOOT PAD; GASTROINTESTINAL MUCOSA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA VIRUS A H1N1; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; VIRUS IMMUNITY; WILD TYPE;

EID: 77249156414     PISSN: 19330219     EISSN: None     Source Type: Journal    
DOI: 10.1038/mi.2009.120     Document Type: Article

References (47)

1. Gribar, S. C., Richardson, W. M., Sodhi, C. P. & Hackam, D. J. No longer an innocent bystander: epithelial Toll-like receptor signaling in the development of mucosal inflammation. Mol. Med. 14, 645-659 ( 2008 ).
2. Vroling, A. B., Fokkens, W. J. & Van Drunen, C. M. How epithelial cells detect danger: aiding the immune response. Allergy 63, 1110-1123 ( 2008 ).
3. Le Goffic, R. et al. Cutting Edge: Influenza A virus activates TLR3- dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J. Immunol. 178, 3368-3372 ( 2007 ).
4. Le Goffic, R. et al. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog. 2, e53 ( 2006 ).
5. Buchweitz, J. P., Harkema, J. R. & Kaminski, N. E. Time-dependent airway epithelial and inflammatory cell responses induced by influenza virus A/ PR/8/34 in C57BL/6 mice. Toxicol. Pathol. 35, 424-435 ( 2007 ).
6. Serkedjieva, J., Toshkova, R., Antonova-Nikolova, S., Stefanova, T., Teodosieva, A. & Ivanova, I. Effect of a plant polyphenol-rich extract on the lung protease activities of influenza-virus-infected mice. Antivir. Chem. Chemother. 18, 75-82 ( 2007 ).
7. Janeway, C. A., Jr. & Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol. 20, 197-216 ( 2002 ).
8. Akira, S. & Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499-511 ( 2004 ).
9. Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783-801 ( 2006 ).
10. Steinhoff, M. et al. Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr. Rev. 26, 1-43 ( 2005 ).
11. Ramachandran, R. & Hollenberg, M. D. Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more. Br. J. Pharmacol. 153, S263-S282 ( 2008 ).
12. Sun, G., Stacey, M. A., Schmidt, M., Mori, L. & Mattoli, S. Interaction of mite allergens Der p3 and Der p9 with protease-activated receptor-2 expressed by lung epithelial cells. J. Immunol. 167, 1014-1021 ( 2001 ).
13. Chung, W. O., Hansen, S. R., Rao, D. & Dale, B. A. Protease-activated receptor signaling increases epithelial antimicrobial peptide expression. J. Immunol. 173, 5165-5170 ( 2004 ).
14. Kida, Y., Inoue, H., Shimizu, T. & Kuwano, K. Serratia marcescens serralysin induces inflammatory responses through protease-activated receptor 2. Infect. Immun. 75, 164-174 ( 2007 ).
15. Dommisch, H. et al. Protease-activated receptor 2 mediates human betadefensin 2 and CC chemokine ligand 20 mRNA expression in response to proteases secreted by Porphyromonas gingivalis. Infect. Immun. 75, 4326-4333 ( 2007 ).
16. Moraes, T. J. et al. Role of PAR2 in murine pulmonary pseudomonal infection. Am. J. Physiol. Lung Cell. Mol. Physiol. 294, L368 - 377 ( 2008 ).
17. Devlin, M. G., Gasser, R. B. & Cocks, T. M. Initial support for the hypothesis that PAR 2 is involved in the immune response to Nippostrongylus brasiliensis in mice. Parasitol. Res. 101, 105-109 ( 2007 ).
18. Moretti, S. et al. The contribution of PARs to inflammation and immunity to fungi. Mucosal Immunol. 1, 156-168 ( 2008 ).
19. Trinchieri, G. & Sher, A. Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol. 7, 179-190 ( 2007 ).
20. O ' Neill, L. A. When signaling pathways collide: positive and negative regulation of Toll-like receptor signal transduction. Immunity 29, 12-20 ( 2008 ).
21. Fyfe, M., Bergstrom, M., Aspengren, S. & Peterson, A. PAR-2 activation in intestinal epithelial cells potentiates interleukin-1β -induced chemokine secretion via MAP kinase signaling pathways. Cytokine 31, 358-367 ( 2005 ).
22. Ostrowska, E., Sokolova, E. & Reiser, G. PAR-2 activation and LPS synergistically enhance inflammatory signaling in airway epithelial cells by raising PAR expression level and interleukin-8 release. Am. J. Physiol. Lung Cell. Mol. Physiol. 293, L1208 - 1218 ( 2007 ).
23. Rallabhandi, P. et al. Analysis of proteinase-activated receptor 2 and TLR4 signal transduction: a novel paradigm for receptor cooperativity. J. Biol. Chem. 283, 24314-24325 ( 2008 ).
24. Uehara, A., Hirabayashi, Y. & Takada, H. Antibodies to proteinase 3 prime human oral, lung, and kidney epithelial cells to secrete proinflammatory cytokines upon stimulation with agonists to various Toll-like receptors, NOD1, and NOD2. Clin. Vaccine Immunol. 15, 1060-1066 ( 2008 ).
25. Doyle, S. et al. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 17, 251-263 ( 2002 ).
26. Doyle, S. E., O ' Connell, R., Vaidya, S. A., Chowoyle, E. K., Yee, K. & Cheng, G. Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4. J. Immunol. 170, 3565-3571 ( 2003 ).
27. Toshchakov, V. et al. TLR4, but not TLR2, mediates IFN-β -induced STAT1α /β -dependent gene expression in macrophages. Nat. Immunol. 3, 392-398 ( 2002 ).
28. Nhu, Q. M., Cuesta, N. & Vogel, S. N. Transcriptional regulation of lipopolysaccharide (LPS)-induced Toll-like receptor (TLR) expression in murine macrophages: role of interferon regulatory factors 1 (IRF-1) and 2 (IRF-2). J. Endotoxin Res. 12, 285-295 ( 2006 ).
29. Vergnolle, N., Hollenberg, M. D., Sharkey, K. A. & Wallace, J. L. Characterization of the inflammatory response to proteinase-activated receptor-2 (PAR2)-activating peptides in the rat paw. Br. J. Pharmacol. 127, 1083-1090 ( 1999 ).
30. Kawai, T. & Akira, S. Innate immune recognition of viral infection. Nat. Immunol. 7, 131-137 ( 2006 ). (Pubitemid 43135878)
31. Jiang, Z., Mak, T. W., Sen, G. & Li, X. Toll-like receptor 3-mediated activation of NF-κB and IRF3 diverges at Toll-IL-1 receptor domaincontaining adapter inducing IFN- β. Proc. Natl. Acad. Sci. USA 101, 3533-3538 ( 2004 ).
32. Fitzgerald, K. A. et al. IKKε and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4, 491-496 ( 2003 ).
33. Meylan, E. et al. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-κB activation. Nat. Immunol. 5, 503-507 ( 2004 ).
34. Yoneyama, M., Suhara, W., Fukuhara, Y., Fukuda, M., Nishida, E. & Fujita, T. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/ p300. EMBO J. 17, 1087-1095 ( 1998 ).
35. Antalis, T. M., Shea-Donohue, T., Vogel, S. N., Sears, C. & Fasano, A. Mechanisms of disease: protease functions in intestinal mucosal pathobiology. Nat. Clin. Pract. Gastroenterol. Hepatol. 4, 393-402 ( 2007 ).
36. Khoufache, K. et al. Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN- -dependent pathway. J. Immunol. 182, 7795-7802 ( 2009 ).
37. Eisenbarth, S. C., Piggott, D. A., Huleatt, J. W., Visintin, I., Herrick, C. A. & Bottomly, K. Lipopolysaccharide-enhanced, toll-like receptor 4- dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 196, 1645-1651 ( 2002 ).
38. Damiano, B. P. et al. Cardiovascular responses mediated by proteaseactivated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1. J. Pharmacol. Exp. Ther. 288, 671-678 ( 1999 ).
39. Schmidlin, F. et al. Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway. J. Immunol. 169, 5315-5321 ( 2002 ).
40. Kawabata, A. et al. The protease-activated receptor-2 agonist induces gastric mucus secretion and mucosal cytoprotection. J. Clin. Invest. 107, 1443-1450 ( 2001 ).
41. Cenac, N. et al. Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. Am. J. Pathol. 161, 1903 - 1915 ( 2002 ).
42. Afkhami-Goli, A. et al. Proteinase-activated receptor-2 exerts protective and pathogenic cell type-specific effects in Alzheimer's disease. J. Immunol. 179, 5493-5503 ( 2007 ).
43. Laukkarinen, J. M., Weiss, E. R., van Acker, G. J., Steer, M. L. & Perides, G. Protease-activated receptor-2 exerts contrasting model-specific effects on acute experimental pancreatitis. J. Biol. Chem. 283, 20703-20712 ( 2008 ).
44. Geiss, G. K. et al. Cellular transcriptional profiling in influenza A virusinfected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc. Natl. Acad. Sci. USA 99, 10736-10741 ( 2002 ).
45. Tashiro, M., Ciborowski, P., Klenk, H. D., Pulverer, G. & Rott, R. Role of Staphylococcus protease in the development of influenza pneumonia. Nature 325, 536-537 ( 1987 ).
46. Kido, H., Murakami, M., Oba, K., Chen, Y. & Towatari, T. Cellular proteinases trigger the infectivity of the influenza A and Sendai viruses. Mol. Cells 9, 235-244 ( 1999 ).
47. Teijaro, J. R. et al. Costimulation modulation uncouples protection from immunopathology in memory T cell responses to influenza virus. J. Immunol. 182, 6834-6843 ( 2009 ).